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ABSTRACT
Background: Ischaemic heart disease (IHD) is
currently ranked eighth among the leading causes of
deaths in sub-Saharan Africa (sSA). Yet, effective
population-wide preventive measures targeting risks in
the region are still largely unavailable. We aimed to
review population-wide and individual-level
interventions addressing risk factors of IHD among
adults in sSA.
Methods: A systematic search of MEDLINE, EMBASE,
Global Health and AJOL was conducted to identify
studies focusing on population-wide and individual-
level interventions targeting risks of IHD among adults
in sSA. We conducted a detailed synthesis of basic
findings of selected studies.
Results: A total of 2311 studies were identified, with
only 9 studies meeting our selection criteria. 3 broad
interventions were identified: dietary modifications,
physical activity and community-based health
promotion measures on tobacco and alcohol cessation.
3 studies reported significant reduction in blood
pressure (BP), and another study reported statistically
significant reduction in mean total cholesterol. Other
outcome measures observed ranged from mild to no
reduction in BP, blood glucose, body mass index and
total cholesterol, respectively.
Conclusions: We cannot specify with all certainty
contextually feasible interventions that can be effective
in modifying IHD risk factors in population groups
across sSA. We recommend more research on IHD,
particularly on the understanding of the burden, geared
towards developing and/or strengthening preventive
and treatment interventions for the disease in sSA.
INTRODUCTION
The burden of cardiovascular diseases
(CVDs) has consistently increased across
many world regions over the last three
decades.1 2 Between 1990 and 2013, the
Institute for Health Metrics and Evaluation
reported a median percentage change of
CVDs at 40.8% and 89.2% for global deaths
and years lived with disabilities, respectively.3 4
Increasing cases and deaths from CVDs, espe-
cially Ischaemic Heart Disease (IHD), have
also been reported among young and active
adults globally.5 Global estimates suggest the
figures to be about 93 million cases and 8.1
million deaths from IHD in 2013.3 4 In Africa,
IHD accounted for 361 000 deaths in
2005, and is currently ranked eighth among
the top causes of deaths in the region.6
In sub-Saharan Africa (sSA) alone, it has
been estimated that mortality from IHD may
rise from the current rates by about 70% and
74% among African men and women,
respectively, by 2030.7 Increasing sedentary
lifestyles, tobacco smoking, alcohol consump-
tion, unhealthy diets and the fast rate of
urbanisation and epidemiological transition
across many African settings have been
strongly indicated.5 8
The 2011 United Nations high-level
meeting on non-communicable diseases
(NCDs) focused on developing a compre-
hensive policy framework for the prevention
and control of NCDs globally, especially
across Africa and many low-income and
middle-income countries, where the burden
is fast increasing.9 Current reports from
Africa show that public health response,
access to health services, and availability of
effective interventions and treatment options
Strengths and limitations of this study
▪ This study provides an insight into interventions
targeting known risks of ischaemic heart disease
(IHD) in selected African population groups.
▪ This study identifies substantive gaps in research
and evidence for informed policy decisions on
IHD in sub-Saharan Africa.
▪ Dietary modification, physical activity, health
education and health promotion measures have
been effective IHD preventive strategies in spe-
cific African population groups.
▪ We still cannot generalise and recommend iden-
tified IHD interventions to many African settings,
especially due to varying degrees of heterogen-
eity within and across several African population
groups.
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for NCDs, including IHD, are relatively poor.10 11
Cost-effective interventions have been described in many
high-income settings.12 13 Health education, improving
access to screening and detection of IHD, deploying
inexpensive technologies to arrive at diagnosis and pro-
viding affordable medications for prevention and treat-
ment of heart attacks, have all been practised in many
developed countries with success.12 14 In sSA, substantive
gaps exist in terms of implementation of many of these
interventions due to weak primary healthcare and
health systems, and poor political will.6 15 Moreover, only
a few studies, reviews and randomised controlled trials
(RCTs) have examined the effectiveness of some of
these interventions.6 Therefore, little evidence is avail-
able for informed policy decisions in this African sub-
region.7 A comprehensive synthesis and appraisal of the
studies on interventions for IHD in sSA may be neces-
sary towards informing better response and strengthen-
ing existing interventions. We systematically reviewed
available literature on IHD in sSA to identify, synthesise
and appraise population-wide and individual-level inter-
ventions addressing risk factors of IHD among adults,
towards better public health policy and practise in the
region.
METHODS
Research question
IHD is a largely preventable NCD, with deaths estimated
to rise in sSA by over 70% by the year 2030.7 In line with
the aim, this study seeks to address the question: are
there evidence-based interventional measures currently
available to address known risk factors for this prevent-
able disease in the African subregion?
Search strategy
A systematic search of MEDLINE, EMBASE, Global
Health and African Journals Online (AJOL) was con-
ducted in May 2016 to identify relevant studies on IHD
in sSA, with search date set from 1980 to 2015 (table 1).
Further searches were conducted on Google Scholar,
and the reference lists of selected studies were further
hand searched for relevant articles. Countries in sSA
were as provided in the World Bank list of countries,
regions and economies.16
Selection criteria
We included original studies (RCTs, cross-sectional or
cohort studies and quasiexperimental studies) that
described basic interventions used in modifying risk
factors associated with IHD across different countries in
sSA. The outcome measures assessed were changes in
blood pressure (BP), blood glucose, total cholesterol
and body mass index (BMI). We ensured participants in
selected studies were adults aged 18 years and above. We
excluded studies that focused on interventions in chil-
dren. Reviews, commentaries, viewpoints and letters
were also excluded. There were no English Language
restrictions, and no attempt was made to contact authors
of articles that were not selected.
Table 1 Search terms on MEDLINE
Number Searches
1 cardiovascular diseases/ or myocardial ischemia/ or angina pectoris/ or coronary disease/ or coronary artery
disease/ or myocardial infarction/
2 ischemic heart disease*.mp. (mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique
identifier]
3 coronary heart disease*.mp. (mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique
identifier)
4 ischaemic heart disease*.mp. (mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique
identifier)
5 "africa south of the sahara”/ or africa, central/ or cameroon/ or central african republic/ or chad/ or congo/ or
“democratic republic of the congo”/ or equatorial guinea/ or gabon/ or africa, eastern/ or comoros/ or burundi/ or
djibouti/ or eritrea/ or ethiopia/ or kenya/ or rwanda/ or seychelles/ or somalia/ or south sudan/or sudan/ or
tanzania/ or uganda/ or africa, southern/ or angola/ or botswana/ or lesotho/ or madagascar/ or malawi/ or
mauritius/ or mozambique/ or namibia/ or sao tome and principe/ or south africa/ or swaziland/ or zambia/ or
zimbabwe/ or africa, western/ or benin/ or burkina faso/ or cape verde/ or cote d’ivoire/ or gambia/ or ghana/ or
guinea/ or guinea-bissau/ or liberia/ or mali/ or mauritania/ or niger/ or nigeria/ or senegal/ or sierra leone/ or togo/
6 subsaharan africa.mp. (mp=title, abstract, original title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier)
7 1 or 2 or 3 or 4
8 5 or 6
9 7 and 8
Searches on EMBASE, Global Health and AJOL were slightly modified.
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Case definitions
We mainly considered studies that focused on interven-
tions addressing known risk factors IHD, including high
BP, diabetes mellitus, hypercholesterolaemia, overweight
and obesity and tobacco smoking.17 IHD was defined as a
group of heart and vascular events characterised by nar-
rowing of arteries with reduced blood and oxygen supply
to the heart muscle.18 Diagnosis, when described, may be
based on ECG findings, echocardiogram or relevant
imaging findings, cardiac enzymes and/or tissue-specific
cardiac biomarkers.18 19 IHD is also often referred to as
‘coronary artery disease’ or ‘coronary heart disease’
(CHD); in such cases, we generally checked for any
reported evidence of intervention targeting risk of ischae-
mic myocardial necrosis to satisfy inclusion in our review.
Quality assessment
The quality of selected studies was assessed using the
Jadad scale.20 Studies were graded between 1 and 5, with
5 being the highest and 1 the lowest. Criteria employed
were randomisation, blinding and accountability of all
participants. Details of the grading of each study are in
the online supplementary file.
Data extraction and synthesis
Data were double extracted from each study and stored
in Microsoft Excel file format. We extracted data on
overall study characteristics including study period,
country, location and setting, method of participant
recruitment, number and mean age of participants,
intervention implemented, follow-up period and assess-
ment of outcome variables. We did not conduct any
meta-analysis in this review due to varying heterogenei-
ties observed within and between population groups in
the selected studies. A qualitative synthesis, as well as evi-
dence appraisal based on relevant information obtained
from selected studies was conducted (see online supple-
mentary file). A PRISMA checklist was used to assess the
completeness of all stages of our review.
RESULTS
Our search returned 2311 records. Only nine studies
met our inclusion criteria and were retained for qualita-
tive synthesis.21–29 The reasons for the excluded studies
are as highlighted in figure 1. Individual study character-
istics are shown in table 2.
Our findings showed that population-wide and
individual-level interventions conducted across selected
studies included dietary modification, physical activity,
health education and health promotion activities on
tobacco and alcohol cessation. These interventions were
primarily aimed at reducing metabolic risk factors for
IHD, such as hypertension, diabetes, obesity and hyper-
cholesterolaemia (table 2 and see online supplementary
file).
Five of the retained studies employed dietary modifica-
tion in addressing hypertension and hypercholesterol-
aemia associated with IHD.21 22 24 27 29 Four studies
focused on salt intake and its relationship with
BP,21 22 24 27 while the fifth study focused on modifying
Figure 1 Flow chart of study selection.
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Table 2 Characteristics of included studies
Studies Country, location (setting) Study design Type of intervention Results
Adeyemo et al21 Nigeria, Igbo-Ora and Idere
(rural)
Feasibility study Dietary modification Reduction observed in 24-hour urinary sodium excretion,
and in systolic and diastolic blood pressure
Cappuccio et al22 Ghana, Ejisu-Juabeng and
Kumasi districts (rural and
semiurban)
Cluster randomised trial Dietary modification
and health promotion
Significant reduction in systolic and diastolic blood
pressure, and changes observed in 24-hour urinary
sodium excretion
Dowse et al23 Mauritius (semiurban) Cross-sectional survey Health education and
health promotion
Reduction in blood pressure, increased physical activity,
but no effect observed on BMI. There was an unusual
increase in blood sugar
Forrester et al24 Nigeria, Igbo-Ora and Idere
(rural)
Randomised control trial Dietary modification No significant association observed between changes in
salt and blood pressure
Grace et al25 South Africa, Mpumalanga and
Gauteng (rural)
Non-randomised trial Physical activity and
health promotion
Minimal reductions observed in BMI and blood pressure.
No reduction observed in total serum cholesterol
Mendis et al26 Nigeria (semiurban) Cluster randomised trial Health education and
health promotion
Significant reduction observed in blood pressure levels
Mtabaji et al27 Tanzania (semiurban) Randomised control trial Dietary modification A significant reduction in arterial blood pressure among
male normotensives placed on low salt diet compared to
those on high salt diet
Rossouw et al28 South Africa, South-Western
Cape (rural)
Quasi-experimental design Health education and
health promotion
Reduction in blood pressure in both sexes, and minimal
reduction in BMI among females
Uusitalo et al29 Mauritius (semiurban) Cross-sectional survey Dietary modification Positive reduction observed in total serum cholesterol
BMI, body mass index.
4
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the content of a commonly used cooking oil targeted at
reducing total cholesterol concentration.29
In the study by Adeyemo et al,21 the effects of reducing
cooking salt among free-living normotensive individuals
in two rural communities in south-western Nigeria were
examined. There was at least 50 mmol reduction in
24-hour urinary sodium in 67% of the participants, and
25 mmol reduction in 84% of the participants.
Reductions were also observed in the systolic and dia-
stolic BP of participants, with the mean systolic BP redu-
cing by 4.7 and 7.0 mm Hg among men and women,
respectively, after 2 weeks. A similar finding was reported
in Tanzania by Mtabaji et al,27 with a significant reduc-
tion in arterial BP among male normotensives placed on
low salt diet compared to those on high salt diet. The
study further reported that those on low salt diet had a
urinary sodium excretion of 52 mmol/day relative to a
320 mmol/day observed among those on high salt diet.
In Ghana, Cappuccio et al22 also examined the effects of
not adding salt while cooking, and reducing the con-
sumption of preserved salted foods on urinary sodium
excretion and BP among 1013 adult participants in both
rural and semiurban settings. Significant reduction in
the systolic and diastolic BP, as well as urinary sodium,
was observed in the intervention group compared with
control, especially after 6 months of restriction of salt
intake. The study concluded that a relative decrease in
BP may be observed with reduced salt intake in the West
Africa subregion. However, in a Nigerian study involving
58 participants from two rural communities, Forrester
et al24 reported that no significant association was
observed between measured changes in dietary salt and
systolic or diastolic BP (p=0.08). In this study, outcome
measures showed that the mean change in systolic and
diastolic BP for both the low salt and high salt phases
differed by 4.8 and 3.2 mm Hg, respectively.24
In Mauritius, Uusitalo et al29 examined the effect of
modifying commonly used cooking oil (ration oil) on
mean serum cholesterol concentration among 1926 par-
ticipants. The main composition of the ration oil was
mostly palm oil which was high in saturated and mono-
unsaturated fatty acids. The ration oil was modified to
entirely soya bean oil. At baseline, 86% of participants
used ration oil. During the 5-year follow-up, 53% of par-
ticipants used the modified ration oil. The mean choles-
terol concentration at baseline was 5.5 mmol/L, with
this reducing to 4.7 mmol/L at follow-up. This reduction
was statistically significant for both men and women
(p<0.001).
Only one study examined the effect of physical activity
on some selected health measures such as BP, body mass
index (BMI) and plasma cholesterol concentration.25
The study was conducted among 143 male South
African colliery executives recruited across two South
African provinces, Mpumalanga and Gauteng. The parti-
cipants were exposed to a physical fitness programme in
the control group and a physical fitness programme
combined with a health promotion intervention pro-
gramme in the experimental group for 32 weeks. At
32 weeks, there was a reduction in BMI in the experi-
mental group, although, this was not statistically signifi-
cant (p=0.067). The study also observed an
improvement in both the systolic and diastolic BP of par-
ticipants after 16 weeks. Although no statistical signifi-
cance was observed in the experimental group, the
values at reassessment were better than the baseline
values. Moreover, effects of physical activity combined
with health promotion measures on total cholesterol
concentration in the participants were examined over
the same 32-week period.25 There were no changes in
total cholesterol observed during the 16 and 32 weeks
reassessment in the experimental group. A moderate
increase was observed in the cholesterol concentration
of the control group during the 16-week reassessment.
The third intervention identified was health educa-
tion/promotion measures. Three studies were identified,
and targeted essentially the effects of tobacco smoking
cessation and alcohol consumption reduction on hyper-
tension, hypercholesterolaemia, diabetes and
obesity.23 26 28 Other selected studies also had some
forms of health education messages along with their tar-
geted intervention, although these were non-specific.
In Mauritius, Dowse et al23 examined the effects of
some health education/promotion activities on the
prevalence of IHD risk factors among 5162 participants
over a 5-year period (1987–1992). The study employed
the use of mass media campaigns, widespread commu-
nity, school and workplace health education activities to
promote increased physical activity, healthy diet,
smoking cessation and reduction in alcohol consump-
tion. While the interventions resulted in a significant
reduction in the prevalence of hypertension in both
men and women participants (p<0.001), no positive
effects were observed in BMI, and no statistically signifi-
cant reduction was observed in mean fasting blood
glucose.25 In a larger South African study involving 7188
participants, Rossouw et al28 observed a reduction in BP
in both men and women participants, and a reduction
in BMI only among the women participants after a
4-year health education/promotion intervention
programme.
In Nigeria, Mendis et al26 investigated the effectiveness
of WHO CVD risk management health promotion
package in reducing BP in primary care settings, and in
improving adherence to lifestyle changes at the individ-
ual and cluster levels among 1188 participants. The
intervention involved assessment and management of
cardiovascular risk factors, and counselling on risk
factors control such as physical activity, diet and tobacco
cessation. There was a reduction in BP which was more
in the intervention group than the control group. In the
intervention group, all participants reported quitting
smoking, while 74.4% reported quitting smoking in the
control group (p=0.023).
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DISCUSSION
This systematic review examined population-wide and
individual-level interventions that focused on modifica-
tion of risk factors associated with IHD in sSA. Our find-
ings suggest there may be effective IHD-preventive
strategies specific for African population groups, with
dietary modification, physical activity, health education/
promotion activities being the main measures reported.
The findings from studies on effects of dietary modifi-
cations indicate that meals low in fats and salts may
reduce major IHD risks, including hypertension and
hypercholesterolaemia.21 22 24 27 29 However, not all
studies reported a statistically significant relationship,
suggesting there are still uncertainties on the role of
dietary salts and fats in reducing risks of IHD. Hooper
and colleagues, however, reported that evidence
obtained from large and small trials revealed that low
sodium diet may help in lowering BP after withdrawing
antihypertensives. Hooper further noted that a compre-
hensive dietary and nutritional plan addressing salt and
fat consumption may be very helpful at reducing risks of
CVDs in a population.30
Physical activity, as a sole intervention for modifying
risks of CVDs, was implemented in just one study, with
the authors not clearly stating how physical activity can
effectively modify risk factors associated with IHD
among adults.25 However, several studies have revealed
that moderate physical activity and exercise most days of
the week may be associated with significant reduction in
the incidence and mortality from CVDs.31 32 In the
study of 17 944 middle-aged male British civil servants,
free of CHD, the age-standardised cumulative incidence
of CHD was 3.1% among men observing vigorous physi-
cal activity, compared with 6.9% among those with no
physical activity.33 Although, this may not be directly
compared with sSA, due to several contextual differ-
ences, it still possibly suggests such measures could lead
to similar outcomes in the African subregion.
From the included studies, we also noted that
population-wide health education and health promotion
measures can indirectly influence healthy lifestyles and
behavioural changes.23 26 28 Ford et al34 employed a
health promotion model that can relatively address
common risk factors for CVDs, with this accounting for
population-wide improvements in BP, cholesterol,
smoking and physical activity, and sufficient to influence a
change from 44% to 76% in reduction of CHD mortality.
Most of the interventions reported in this review were
community based, suggesting that they may only be feas-
ible and acceptable within contextually similar settings.
The organisation and sustainability of these interven-
tions across many settings in sSA may be difficult due to
prevailing divergent social, cultural and individual
issues. Hence, underlying determinants of IHD, includ-
ing income distribution and educational level specific to
the various population subgroups in the region, need to
be identified and addressed.35 Additionally, interven-
tions targeting behavioural risks in the general
population through a comprehensive risk assessment,
and designing cost-effective management protocols for
the high-risk categories may need to be undertaken
towards ensuring improved cardiovascular health in
sSA.35 Advocacies and policies that allow collaboration
and regular interactions among experts in the academia,
researchers, clinicians, community leaders, government
and non-governmental agencies, may be helpful in insti-
tuting some of these interventions effectively on a
population-wide scale in many indigenous settings in the
region.36 Such policy frameworks may need to be jointly
developed by the various stakeholders to aid effective
implementation, monitoring and evaluation across the
subcontinent.
Our study is not without limitations. Despite a rigorous
search across several electronic databases, the number of
studies retained was relatively small to fully reflect the
entire sSA population. Moreover, only five countries
were represented in this review (Ghana, Mauritius,
Nigeria, South Africa and Tanzania), meaning that find-
ings are more likely to reflect the conditions in these set-
tings. There were obvious heterogeneities across the
selected studies. As such, a meta-analysis, which could
have provided a regional pooled estimate on the effect-
iveness of these interventions in sSA, was not conducted.
We cannot, therefore, state with all certainty specific
interventions for IHD that can be applied, modelled or
replicated in sSA. We also understand there are several
interventions that have been studied in many settings
outside sSA; a contextual comparison of these to African
countries would have been worthwhile, but discussing
this would simply be beyond the aims of this study.
Additionally, WHO already provided a comprehensive
Package of Essential Non-communicable disease interven-
tions for primary healthcare in less developed settings,
with a focus on improving maternal nutrition, implement-
ing tobacco prevention and cessation programmes,
improving affordability of food, encouraging physical
activity and providing access to effective prevention and
care of risks and diseases;37 our review would have been
more detailed if assessments of these interventions were
identified across selected studies. However, due to very
low research output and a relative lack of understanding
of the burden of IHD in sSA, we believe our report
may contribute to relevant research and policy response
on IHD risk factors and interventions across countries in
the region.
CONCLUSION
The rising burden of IHD in sSA without effective
population-wide interventions remains a huge public
health concern in the region. Hitherto, little has been
known on the epidemiology, treatment options and
overall public health response to IHD in Africa. Our
findings on dietary modifications, physical activity and
relevant health promotion measures may have been sug-
gestive of relative improvements in reducing risks of
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IHD, yet, we still cannot generalise and recommend this
to many African settings, especially due to varying
degrees of heterogeneity within and across population
groups. We recommend more research and active collab-
oration on IHD, particularly on the understanding of its
epidemiological distribution and overall burden in sSA,
targeted towards developing and/or strengthening
population-wide preventive and treatment options across
several settings in the region.
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